The present invention is directed to Buprenorphine Analog compounds of the Formula I, Formula IA or Formula IB shown below, wherein R1, R2, R8, R3a, R3b, G, X, Z and Y are as defined herein. Compounds of the Invention are useful for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors.